» Articles » PMID: 8760599

Dichotomy of Astrocytoma Migration and Proliferation

Overview
Journal Int J Cancer
Specialty Oncology
Date 1996 Jul 17
PMID 8760599
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytomas often show high rates of local invasion that lead to local recurrence of the disease. Histologically, the most highly invasive astrocytoma cells are detected in isolation rather than as nests of tumor. Our study attempted to determine whether the migratory response to extracellular substrates influences the proliferative behavior of these highly invasive cells. The preferential and specific migratory response of human astrocytoma cells to extracellular matrix proteins was assessed by a microliter scale migration assay. Growth curve studies on protein ligands permissive (merosin) for cell migration indicated that the lag phase was protracted compared with cells seeded on non-permissive proteins (vitronectin). Once a certain cell density was reached, logarithmic proliferation was indistinguishable on the different proteins. The proliferation index of populations of cells migrating on merosin and vitronectin was measured by both BrdU incorporation and MIB-1 immunocytochemistry labeling. Cells seeded on vitronectin showed higher proliferation throughout the population than cells seeded on merosin. On merosin, the more migratory cells at the periphery were less proliferative than non-migratory cells in the central region of that population. The integrin-associated signal transduction protein, p125FAK, was heavily localized in the membrane of non-migrating cells and largely absent in migrating astrocytoma cells. We conclude that temporally, proliferation and migration are mutually exclusive behaviors. Cell density or non-permissive substrates that inhibit cell motility favor a more proliferative phenotype. Conversely, active migration suppresses cell proliferation.

Citing Articles

Hypoxia-Regulated CD44 and xCT Expression Contributes to Late Postoperative Epilepsy in Glioblastoma.

Kusakabe K, Inoue A, Ohnishi T, Nakamura Y, Ohtsuka Y, Nishikawa M Biomedicines. 2025; 13(2).

PMID: 40002787 PMC: 11853413. DOI: 10.3390/biomedicines13020372.


Global regulators enable bacterial adaptation to a phenotypic trade-off.

Deyell M, Opuu V, Griffiths A, Tans S, Nghe P iScience. 2025; 28(1):111521.

PMID: 39811663 PMC: 11731283. DOI: 10.1016/j.isci.2024.111521.


Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model.

Shojaee P, Weinholtz E, Schaadt N, Feuerhake F, Hatzikirou H NPJ Syst Biol Appl. 2025; 11(1):3.

PMID: 39779740 PMC: 11711667. DOI: 10.1038/s41540-024-00478-7.


Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro.

Mokoena X, Mabeta P, Cordier W, Flepisi B J Neurooncol. 2024; 171(2):443-453.

PMID: 39538037 PMC: 11695387. DOI: 10.1007/s11060-024-04870-5.


mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration.

Eder I, Yu V, Antonello J, Chen F, Gau D, Chawla P Mol Biol Cell. 2024; 35(10):ar133.

PMID: 39196658 PMC: 11481706. DOI: 10.1091/mbc.E24-01-0008.